Show simple item record

Opioid [delta]-receptor involvement in supraspinal and spinal antinociception in mice

dc.contributor.authorHeyman, Julius S.en_US
dc.contributor.authorMulvaney, Sheila A.en_US
dc.contributor.authorMosberg, Henry I.en_US
dc.contributor.authorPorreca, Franken_US
dc.date.accessioned2006-04-07T19:48:36Z
dc.date.available2006-04-07T19:48:36Z
dc.date.issued1987-09-08en_US
dc.identifier.citationHeyman, Julius S., Mulvaney, Sheila A., Mosberg, Henry I., Porreca, Frank (1987/09/08)."Opioid [delta]-receptor involvement in supraspinal and spinal antinociception in mice." Brain Research 420(1): 100-108. <http://hdl.handle.net/2027.42/26577>en_US
dc.identifier.urihttp://www.sciencedirect.com/science/article/B6SYR-4836162-28K/2/aeea0eaf588160e5830161be6dc6c3a0en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/26577
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2823970&dopt=citationen_US
dc.description.abstractThe possibility that the opioid [delta]-receptor mediates antinociception in tests where heat is the noxious stimulus was investigated using highly selective [mu]- and [delta]-agonists and -antagonists. Antinociceptive dose-response curves were constructed for [mu] ([-Ala2, NMePhe4, Gly-ol]enkephalin, DAGO; morphine) and [delta] ([-Pen2,-Pen5]enkephalin, DPDPE)-agonist in the absence, and in the presence of the [mu] non-surmountable antagonist, [beta]-funaltrexamine ([beta]-FNA) or the [delta]-antagonist ICI 174,864 (N,N-diallyl-Tyr-Aib-Aib-Phe-Leu- OH, where Aib is [alpha]-amino-isobutyric acid). Agonists and ICI 174,864 were given alone or in the same intracerebroventicular (i.c.v.) or intrathecal (i.th.) injection to mice 20 min prior to testing in the warm-water (55 [deg]C) tail-withdrawal test (+10 min for i.th. DPDPE); [beta]-FNA was given as a single i.c.v. or i.th. pretreatment dose (20 and 0.01 nM, respectively) 4 hr with [beta]-FNA resulted in a rightward displacement of the DAGO and morphine antinociceptive dose-response lines, but failed to displace the i.c.v. DPDPE curve. Similarly, i.th. pretreatment with [beta]-FNA displaced the i.th. morphine dose-response curve to the right without affecting the i.th. DPDPE antinociceptive dose-response line. ICI 174,864 (1 and 3 [mu]g) produced a dose-related antagonism of i.c.v. or i.th. DPDPE, but did not alter the antinociceptive effects of DAGO or morphine given by the same routes. Co-administration of ICI 174 864 ([mu]g) i.c.v. morphine in [beta]-FNA pretreated (but not control) mkce resulted in a further rightward displacement of the morphine dose-response line. The effective antagonism of DPDPE but not morphine or DAGO antinociception by ICI 174,864, together with the effectiveness of [beta]-FNA against morphine and DAGO but not DPDPE antinociception, provide strong and direct evidence for the involvement of cerebral and spinal [delta]-receptors in the mediation of antinociception in tests where heat is employed as the noxious stimulus. Additionally, the effectiveness of ICI 174,864 against morphine in [beta]-FNA pretreated (but not control) mice demonstrates a [delta]-effect of morphine, in vivo.en_US
dc.format.extent712961 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherElsevieren_US
dc.titleOpioid [delta]-receptor involvement in supraspinal and spinal antinociception in miceen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumCollege of Pharmacy, University of Michigan, Ann Arbor, MI 48109, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Pharmacology, University of Arizona Health Sciences Center, Tucson, AZ 85724, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Pharmacology, University of Arizona Health Sciences Center, Tucson, AZ 85724, U.S.A.en_US
dc.contributor.affiliationotherDepartment of Pharmacology, University of Arizona Health Sciences Center, Tucson, AZ 85724, U.S.A.en_US
dc.identifier.pmid2823970en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/26577/1/0000116.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1016/0006-8993(87)90244-7en_US
dc.identifier.sourceBrain Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.